SeaCrest Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $211K | Sell |
474
-289
| -38% | -$129K | 0.02% | 563 |
|
|
2025
Q1 | $370K | Buy |
+763
| New | +$370K | 0.04% | 413 |
|
|
2020
Q4 | – | Sell |
-1,361
| Closed | -$370K | – | 649 |
|
|
2020
Q3 | $370K | Hold |
1,361
| – | – | 0.06% | 327 |
|
|
2020
Q2 | $395K | Buy |
1,361
+145
| +12% | +$42.1K | 0.07% | 306 |
|
|
2020
Q1 | $289K | Buy |
+1,216
| New | +$289K | 0.06% | 332 |
|
|
2019
Q2 | – | Sell |
-459
| Closed | -$84K | – | 1817 |
|
|
2019
Q1 | $84K | Sell |
459
-4
| -0.9% | -$732 | 0.01% | 761 |
|
|
2018
Q4 | $77K | Sell |
463
-699
| -60% | -$116K | 0.02% | 759 |
|
|
2018
Q3 | $224K | Sell |
1,162
-50
| -4% | -$9.64K | 0.04% | 469 |
|
|
2018
Q2 | $206K | Sell |
1,212
-121
| -9% | -$20.6K | 0.04% | 480 |
|
|
2018
Q1 | $217K | Buy |
1,333
+108
| +9% | +$17.6K | 0.04% | 466 |
|
|
2017
Q4 | $184K | Buy |
+1,225
| New | +$184K | 0.03% | 523 |
|